237 related articles for article (PubMed ID: 2827895)
1. A major 50-kDa human B-cell growth factor-II induces both Tac antigen expression and proliferation by several types of lymphocytes.
Kawano M; Matsushima K; Masuda A; Oppenheim JJ
Cell Immunol; 1988 Feb; 111(2):273-86. PubMed ID: 2827895
[TBL] [Abstract][Full Text] [Related]
2. Identification of a major 50-kDa molecular weight human B-cell growth factor with Tac antigen-inducing activity on B cells.
Kawano M; Matsushima K; Oppenheim JJ
Cell Immunol; 1987 Aug; 108(1):132-49. PubMed ID: 3111722
[TBL] [Abstract][Full Text] [Related]
3. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells).
Yodoi J; Teshigawara K; Nikaido T; Fukui K; Noma T; Honjo T; Takigawa M; Sasaki M; Minato N; Tsudo M
J Immunol; 1985 Mar; 134(3):1623-30. PubMed ID: 2578514
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a human B cell line that proliferates in response to B cell growth factor.
Abe H; Rossio JL; Ruscetti FW; Matsushima K; Oppenheim JJ
J Immunol Methods; 1986 Jun; 90(1):111-23. PubMed ID: 2423613
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of interleukin 2 vs B cell growth factor on human B cells.
Nakagawa T; Nakagawa N; Ambrus JL; Fauci AS
J Immunol; 1988 Jan; 140(2):465-9. PubMed ID: 2447179
[TBL] [Abstract][Full Text] [Related]
6. Activity of a partially purified human BCGF on murine assays for B-cell stimulatory factors. I. BCGF II-like activity of human BCGF.
Ennist DL; Greenblatt D; Coffman R; Sharma S; Maizel A; Howard M
Cell Immunol; 1987 Nov; 110(1):77-94. PubMed ID: 3499989
[TBL] [Abstract][Full Text] [Related]
7. Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF).
Vazquez A; GĂ©rard JP; Olive D; Auffredou MT; Dugas B; Karray S; Delfraissy JF; Galanaud P
Eur J Immunol; 1986 Dec; 16(12):1503-7. PubMed ID: 3102243
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function.
Muraguchi A; Kehrl JH; Longo DL; Volkman DJ; Smith KA; Fauci AS
J Exp Med; 1985 Jan; 161(1):181-97. PubMed ID: 2981952
[TBL] [Abstract][Full Text] [Related]
9. Effect of interleukin 1 on the expression of interleukin 2 receptor (Tac antigen) on human natural killer cells and natural killer-like cell line (YT cells).
Shirakawa F; Tanaka Y; Eto S; Suzuki H; Yodoi J; Yamashita U
J Immunol; 1986 Jul; 137(2):551-6. PubMed ID: 3013994
[TBL] [Abstract][Full Text] [Related]
10. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
Tseng CT; Springgate CF; Piela TH; Choi YS
J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
[TBL] [Abstract][Full Text] [Related]
12. Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines.
Lasky JL; Thorbecke GJ
Eur J Immunol; 1989 Feb; 19(2):365-71. PubMed ID: 2495224
[TBL] [Abstract][Full Text] [Related]
13. Recombinant interleukin 2 or 5, but not 3 or 4, induces maturation of resting mouse B lymphocytes and propagates proliferation of activated B cell blasts.
Karasuyama H; Rolink A; Melchers F
J Exp Med; 1988 Apr; 167(4):1377-90. PubMed ID: 3128631
[TBL] [Abstract][Full Text] [Related]
14. Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line.
Scala G; Kuang YD; Hall RE; Muchmore AV; Oppenheim JJ
J Exp Med; 1984 Jun; 159(6):1637-52. PubMed ID: 6327874
[TBL] [Abstract][Full Text] [Related]
15. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
Kehrl JH; Grove JH; Goldsmith PK; Fauci AS
Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
[TBL] [Abstract][Full Text] [Related]
16. B-cell-derived interleukin 1 (IL-1)-like factor. I. Relationship of production of IL-1-like factor to accessory cell function of Epstein-Barr virus-transformed human B-lymphoblast lines.
Matsushima K; Kuang YD; Tosato G; Hopkins SJ; Oppenheim JJ
Cell Immunol; 1985 Sep; 94(2):406-17. PubMed ID: 2992808
[TBL] [Abstract][Full Text] [Related]
17. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40).
Ledbetter JA; Shu G; Gallagher M; Clark EA
J Immunol; 1987 Feb; 138(3):788-94. PubMed ID: 3492534
[TBL] [Abstract][Full Text] [Related]
19. Human BCGF-12kD functions as an autocrine growth factor in transformed B cells.
Kumar A; Vasquez A; Maizel AL; Sharma S
Eur Cytokine Netw; 1990; 1(2):109-13. PubMed ID: 1966378
[TBL] [Abstract][Full Text] [Related]
20. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]